According to the latest report by IMARC Group, titled “Medical Simulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global medical simulation market size reached US$ 2.2 Billion in 2022. Medical simulation is a virtual representation of in-situ operations that provides a safer learning atmosphere to practitioners and researchers for examining new clinical procedures and training individuals regarding various medical fields. It employs advanced technologies, high-fidelity body manikins, task trainers, and virtual reality (VR)-based systems to teach laparoscopic, gynecological, cardiovascular, arthroscopic, endovascular, dental, and ocular procedures. It further comprises a set of video cameras and acoustic systems that enables professors, academicians, and peers to connect, communicate and deliver valuable feedback to trainees. Medical simulator helps to foster multidisciplinary teamwork, improve psychomotor attributes and enhance crisis resource management. As a result, medical simulation is extensively used by educational institutes and research centers in varying settings, including the classroom, situational environments, and areas explicitly designed to create real-life clinical scenarios.
Global Medical Simulation Market Trends:
The continuous technological advancements in the healthcare industry and the widespread adoption of advanced teaching approaches and virtual training interactions through deploying Intra-Cardiac Echocardiography (ICE) and cardiac assist devices are majorly driving the market growth. This is further influenced by the shifting user inclination toward online and virtual learning practices, especially during the COVID-19 pandemic. Besides this, the rising demand for medical simulation across academic and medical institutes due to the lack of proficient healthcare professionals is favoring the market growth. These technologies help trainees gain competence and technical expertise to improve patient safety outcomes and prevent medical errors. Moreover, the growing popularity of minimally invasive treatment procedures is facilitating the medical simulation demand since the majority of its modalities are designed to teach such operations. Additionally, the advent of medical visualization, and surgical robots, to enhance the overall performance of learners is propelling the market growth. Apart from this, the rapid digitization and the integration of robotics, virtual or augmented reality (AR), and artificial intelligence (AI) solutions in interventional simulators are contributing to the market growth. Looking forward, the market value is projected to reach US$ 4.7 Billion by 2028, expanding at a CAGR of 13.32% during 2023-2028.
- Based on product and services, the market is segregated into model-based, surgical, ultrasound web-based, and training services simulation.
- On the basis of fidelity, the market has been divided into low, medium, and high fidelity.
- Based on end-user, the market has been categorized into hospitals and clinics, academic institutions and research centers, military organizations, and others.
- On a regional basis, the market has been segmented into North America (the United States
, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Cardionics Inc. (3B Scientific GmbH), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Mentice, Operative Experience Inc., Simbionix USA Corporation (3D Systems), Simulab Corporation, Surgical Science Sweden AB, Synaptive Medical Inc., SynBone AG, and VirtaMed AG.
|Base Year of the Analysis
||Product and Services, Fidelity, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Cardionics Inc. (3B Scientific GmbH), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Mentice, Operative Experience Inc., Simbionix USA Corporation (3D Systems), Simulab Corporation, Surgical Science Sweden AB, Synaptive Medical Inc., SynBone AG and VirtaMed AG
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800